High caffeine levels associated with weight loss and type 2 diabetes risk: BMJ

Published Date: 17 Mar 2023

UK: A recent study published in BMJ Medicine found that more caffeine in the blood can reduce the risk of type 2 diabetes and obesity. more...

Read Full News

Latest News

PCOS Rename? Critics Say PMOS Misses the Mark

While most experts agree that PCOS needed a new name, some participants at ENDO 2026 questioned both the new PMOS terminology and the process used to develop it.

When a Kid’s Bad Behavior Is Actually Hidden Sleep Disorder

In children, the effects of sleep problems may be even more pronounced than in adults because sleep is closely tied to growth, learning, and brain maturation.

Unapproved Retatrutide Use Challenges Clinicians

Non-FDA approved retatrutide is readily available to US consumers from multiple sources, leaving many clinicians grappling with how to manage patients taking the drug.

Imaging Predicts Therapy Failure in T2-T3 Glottic Cancers

Vertical anterior commissure involvement identified on preoperative imaging predicts poor outcomes in patients undergoing primary chemoradiotherapy for T2-T3 glottic tumours.

QOL After Weight-Loss Surgery Persists Despite Regain

In a prospective study, long-term improvements in QOL after metabolic and bariatric surgery are largely maintained in both patients experiencing weight regain of less than 30% and 30% or more.

Bariatric Surgery Outperforms Diet for Cancer Prevention

Metabolic/bariatric surgery is linked to a lower risk for multiple cancers in patients with severe obesity than dietary counseling, a large analysis shows.

Todays Updates

Induction Immunotherapy Has Durable Survival Benefit in LACC

Patients with locally advanced cervical cancer who receive dual checkpoint blockade before standard chemoradiation have high 3-year survival, but outcomes are poorer for those with ‘cold’ tumors.

Todays Updates

Induction Immunotherapy Has Durable Survival Benefit in LACC

Patients with locally advanced cervical cancer who receive dual checkpoint blockade before standard chemoradiation have high 3-year survival, but outcomes are poorer for those with ‘cold’ tumors.

Latest News

While most experts agree that PCOS needed a new name, some participants at ENDO 2026 questioned both the new PMOS terminology and the process used to develop it.

In children, the effects of sleep problems may be even more pronounced than in adults because sleep is closely tied to growth, learning, and brain maturation.

Non-FDA approved retatrutide is readily available to US consumers from multiple sources, leaving many clinicians grappling with how to manage patients taking the drug.

Vertical anterior commissure involvement identified on preoperative imaging predicts poor outcomes in patients undergoing primary chemoradiotherapy for T2-T3 glottic tumours.

In a prospective study, long-term improvements in QOL after metabolic and bariatric surgery are largely maintained in both patients experiencing weight regain of less than 30% and 30% or more.

Metabolic/bariatric surgery is linked to a lower risk for multiple cancers in patients with severe obesity than dietary counseling, a large analysis shows.

News All Time

Fasting and Calorie Restriction Work via Different Pathways

In adults with obesity, both intermittent fasting and calorie restriction lead to significant weight loss but act through distinct behavioral pathways.

GLP-1s Tied to Reduced Opioid Use in Chronic Pancreatitis

Among patients with chronic pancreatitis, GLP‑1 treatment is associated with a lower likelihood of initiating long-term opioid therapy or developing opioid use disorder.

NHS Recommends First Drug to Delay Type 1 Diabetes

NICE has recommended teplizumab — the first medicine to delay type 1 diabetes onset — in what Diabetes UK calls ‘a new age of treatment.’

GLP-1 Era Demands a New Model of Obesity Care

Panelists at HLTH Europe 2026 say obesity care must shift to lifelong digital models and shed its stigma as a moral failing.

Medicare to Cover New Osteoporosis Diagnostic Screening Test

Medicare coverage of a new osteoporosis screening tool may help to address the challenge of identifying and treating patients with osteoporosis by expanding access to screening.

Erosive Hand OA Flags Fracture Risk in Postmenopausal Women

Erosive hand osteoarthritis is associated with an increased risk for incident osteoporotic fractures in postmenopausal women, a study finds.

10-Hour Eating Window Boosts Weight Loss in Obesity

10-hour time-restricted eating promotes greater weight loss and improved body composition in adults with obesity and without diabetes than standard dietary counseling alone.

US Health Department Proposes Testosterone Therapy Label Updates

The U.S. health department said on Thursday it was seeking updates to labels for testosterone replacement therapies after reviewing new clinical data ⁠and other...

The HPV Vaccine at 20: Progress Made, Challenges Ahead

Evidence supports HPV vaccination as a powerful cancer prevention tool, but improving its uptake remains critical for achieving long-term public health goals.

AGA Updates POWER Guide for Obesity, Weight Management

Updated guidance from the American Gastroenterological Association aims to help clinicians navigate the growing number of obesity and weight-management treatment options.

Breast Cancer Patients Taking GLP-1s Had Better Survival

The findings from a large observational study underscore the need for randomized clinical trials to assess the relationship between GLP-1 use and outcomes in patients with cancer.

MRI Predicts Survival Better Than Pathology in Rectal Cancer

MRI provides a more reliable preoperative prediction of survival and recurrence in patients with rectal tumour than traditional histopathology.

Early Use Of Novocure's Brain Cancer Therapy Shows no Significant Survival Benefit in Late-stage Trial

Novocure said on Thursday that a late-stage trial showed early use of its non-invasive cancer therapy ⁠did not significantly improve overall survival in patients with newly...

GLP-1s Could Help Improve Symptoms of PMOS

The metabolic symptoms of PMOS, including overweight and diabetes, may be effectively treated by GLP-1s.

Medicine Shortages Among Worst Ever Seen, Pharmacists Warn

Health leaders are calling for an emergency taskforce as record-breaking shortages hit patients and stretch pharmacies to the limit.

Tirzepatide Tops Semaglutide in Real-World Weight Loss

Tirzepatide leads to greater and faster weight loss than semaglutide in a real-world analysis of more than 20,000 patients with obesity.

Recommended News For You

ctDNA Predicts Relapse in Locally Advanced Cervical Cancer

Bladder cancer link to explosive ordnance exposure among Army veteran bomb disposal officers

Study offers clearer picture of childhood brain tumor survival

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

How access to specialized cancer centers affects glioblastoma outcomes

Triplet Therapy Improves Posttransplant Outcomes in Myeloma

Does pollution cause cancer?

Recommended Articles For You

Case Study: Artificial Intelligence in Early Cancer Detection 

Understanding Hemosiderosis: Causes, Symptoms, and Treatment Options 

Oncology Drug Trends 2025: FDA Approvals, Immuno-Oncology, and Clinical Trial Insights 

Beta-2 Microglobulin: Function, Role in Disease & Clinical Significance Explained 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Can Concurrent Boost Safely Shorten Breast Cancer Radiation?

2.

Q&A: Why adolescents and young adults with cancer are falling behind

3.

PRO Data Strengthen Case for Dato-DXd in First-Line TNBC

4.

Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.

5.

Ketamine plus psychotherapy for "excellent" PTSD

1.

Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study

2.

The Ultimate Guide to Understanding Abiraterone and its Uses in Cancer Treatment 

3.

Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms

4.

Unlocking the Secret to Accurate ANC Calculation with This Informative Blog Post

5.

Beyond the Standard: Personalized Cancer Vaccines and the Dawn of a New Era in Pediatric Oncology

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Navigating the Complexities of Ph Negative ALL - Part XII

2.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

3.

Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma

4.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot